Importantly, 62.4% of patients developed these events before meeting the official ACR/EULAR classification threshold, ...

Objectives To compare the sensitivity of 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology (EULAR/ACR) classification criteria against 1997 ACR criteria for ...

The American College of Rheumatology (ACR) has released a summary of a guideline with updated recommendations for the treatment of systemic lupus erythematosus (SLE).

Both flare and persistently active disease (PAD) are common disease activity patterns in patients with systemic lupus erythematosus (SLE). A large prospective multinational cohort study, published ...

Article citations More>> Aringer, M., Costenbader, K.H., Daikh, D.I., Brinks, R., Mosca, M., Ramsey-Goldman, R., et al. (2019) 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.

While the 2019 EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Inclusion/Exclusion Criteria Inclusion Criteria 1. Age ≥ 60 years at time of enrollment 2. Normal OCT and VF assessment within 6 months of screening visit 3. Have established SLE (≥ 4 ACR criteria or ...

The RESET-SLE™ trial is a Phase 1/2 open-label study of CABA-201 in subjects with non-renal systemic lupus erythematosus (SLE) and lupus nephritis (LN), each evaluated in individual cohorts.

“The ACR data show that treatment with ESK-001 downregulates key cytokines and disease biomarkers of SLE,” said Dr. Jörn Drappa, Alumis’ Chief Medical Officer.